Publication | Open Access
Intranasal ketorolac versus intravenous ketorolac for treatment of migraine headaches in children: A randomized clinical trial
38
Citations
52
References
2021
Year
Intranasal ketorolac was non-inferior to intravenous ketorolac for reducing migraine headache pain in the emergency department.
| Year | Citations | |
|---|---|---|
Page 1
Page 1